1. Home
  2. FAF vs PTGX Comparison

FAF vs PTGX Comparison

Compare FAF & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First American Corporation (New)

FAF

First American Corporation (New)

HOLD

Current Price

$63.45

Market Cap

6.3B

Sector

Finance

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$103.69

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAF
PTGX
Founded
1889
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.2B
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
FAF
PTGX
Price
$63.45
$103.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$79.00
$108.23
AVG Volume (30 Days)
1.0M
836.1K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
3.45%
N/A
EPS Growth
376.19
N/A
EPS
6.00
N/A
Revenue
$7,452,200,000.00
N/A
Revenue This Year
$8.08
$873.97
Revenue Next Year
$5.46
N/A
P/E Ratio
$10.61
N/A
Revenue Growth
21.61
N/A
52 Week Low
$53.95
$41.29
52 Week High
$71.47
$107.84

Technical Indicators

Market Signals
Indicator
FAF
PTGX
Relative Strength Index (RSI) 53.82 55.77
Support Level $61.26 $76.63
Resistance Level $63.79 $107.84
Average True Range (ATR) 1.40 4.24
MACD 0.62 -0.37
Stochastic Oscillator 89.77 63.06

Price Performance

Historical Comparison
FAF
PTGX

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: